HomeMy WebLinkAbout10.19.26 Board Correspondence - FW_ It is outrageous to think that Remdesivir continues to be used in hospitals..ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening
attachments, clicking on links, or replying..
From:Clerk of the Board
To:Mutony, Heather
Cc:Lee, Lewis
Subject:Board Correspondence - FW: It is outrageous to think that Remdesivir continues to be used in hospitals.
Date:Monday, October 19, 2026 4:31:03 PM
Attachments:image001.png
Please see Board Correspondence -
Lewis LeeAdministrative Technician - ConfidentialButte County Administration25 County Center Drive, Suite 200 • Oroville, CA 95965T: 530.552.3326www.buttecounty.ca.gov | lelee@buttecounty.ca.gov
From: lance dreiss <lancedreiss@att.net>
Sent: Monday, October 19, 2026 3:20 PM
To: Shared Mailbox Clerk of the Board <pcbs@countyofplumas.com>;
Senator.Dahle@senate.ca.gov; Assemblymember.Gallagher@assembly.ca.gov;
sheriff@countyofplumas.com; District Attorney <District_Attorney@buttecounty.ca.gov>;
Nicolereinert@countyofplumas.com; danpargee@countyofplumas.com;
davidhollister@countyofplumas.com; Soderstrom, Monica <msoderstrom@buttecounty.ca.gov>;
Durfee, Peter <PDurfee@buttecounty.ca.gov>; Ronald Owens <ronald@muzzledtruth.com>;
Kimmelshue, Tod <TKimmelshue@buttecounty.ca.gov>; Pickett, Andy
<APickett@buttecounty.ca.gov>; Connelly, Bill <BConnelly@buttecounty.ca.gov>; Teeter, Doug
<DTeeter@buttecounty.ca.gov>; Beaudoin, Jarett <JBeaudoin@buttecounty.ca.gov>; Julie Threet
<julie4butte5@gmail.com>; Waugh, Melanie <mwaugh@buttecounty.ca.gov>; Kitts, Melissa
<mkitts@buttecounty.ca.gov>; Ritter, Tami <TRitter@buttecounty.ca.gov>; Teri DuBose
<Teri.DuBose@mail.house.gov>; Clerk of the Board <clerkoftheboard@buttecounty.ca.gov>;
Stephens, Brad J. <BStephens@buttecounty.ca.gov>
Subject: It is outrageous to think that Remdesivir continues to be used in hospitals.
Public Record
It is outrageous to think that remdesivir continues to be used in hospitals.
Hospital protocols in many places still include remdesivir for indicated COVID patients, even as military whistleblower
documents and statements from Brad Miller (resigned Army officer with CHD’s Military Chapter) spotlight a reported 64%
death rate among the 941 servicemembers treated with the drug over a multi-year period from 2020 to 2024. Those
documents, released under the name “The Remdesivir Papers,” also criticize the Department of Defense for not being
forthcoming about the data and raise questions about how the drug was used.
https://t.me/DrPaulMarik/5370
diana dreiss